Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.58 |
| ▸ | NPC1 | O15118 | 4/20 | 0.58 |
| ▸ | RAB9A | P51151 | 4/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.42 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.37 |
| ▸ | IDH1 | O75874 | 4/20 | 0.36 |
| ▸ | IDH2 | P48735 | 1/20 | 0.36 |
| ▸ | PHGDH | O43175 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CBLB | Q13191 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11987645 | 0.93 | NPC1 (0.45) | MAPTNPC1RAB9ASMN1; SMN2ATM | |
| SCHEMBL10327009 | 0.85 | MAPT (0.39) | MAPTNPC1RAB9ASMN1; SMN2ATM | |
| SCHEMBL13780070 | 0.81 | NPC1 (0.47) | MAPTNPC1RAB9ASMN1; SMN2ATM | |
| SCHEMBL10326651 | 0.78 | NPC1 (0.37) | MAPTNPC1RAB9ASMN1; SMN2ATM | |
| SCHEMBL17660049 | 0.78 | MAPT (0.38) | MAPTNPC1RAB9ASMN1; SMN2ATM | |
| SCHEMBL10326643 | 0.77 | NPC1 (0.36) | MAPTNPC1RAB9ASMN1; SMN2ATM | |
| SCHEMBL11987008 | 0.76 | MAPT (0.48) | MAPTNPC1RAB9ASMN1; SMN2ATM | |
| SCHEMBL197523 | 0.75 | MAPT (1.00) | MAPTNPC1RAB9ASMN1; SMN2ATM | |
| SCHEMBL14198216 | 0.75 | IDH1 (0.40) | MAPTNPC1RAB9ASMN1; SMN2ATM | |
| SCHEMBL10326677 | 0.74 | IDH1 (0.35) | MAPTNPC1RAB9ASMN1; SMN2ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150311455-A1 | Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device | UDC IRELAND LTD (IE) | 2015-10-29 | — | — | US | disclosed |
| US-9062084-B2 | Method of forming metal complex compound, and organic electroluminescence device | UDC Ireland (IE) | 2015-06-23 | — | — | US | disclosed |
| US-20120309970-A1 | PLATINUM COMPLEX COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | UDC IRELAND LTD. (IE) | 2012-12-06 | — | — | US | disclosed |
| US-8247091-B2 | Platinum complex compound and organic electroluminescent device | FUJIFILM CORPORATION (JP) | 2012-08-21 | — | — | US | disclosed |
| US-20110234090-A1 | PLATINUM COMPLEX COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | FUJIFILM CORPORATION (JP) | 2011-09-29 | — | — | US | disclosed |
| US-20110050093-A1 | METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110050093-A1 | METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE | ZFR, PORCN, OR10J3 | MAPT 1946/4885NPC1 2788/4885RAB9A 2280/4885 |
| US-20150311455-A1 | Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device | ZFR, PORCN, OR10J3 | MAPT 1946/4885NPC1 2788/4885RAB9A 2280/4885 |
| US-20120309970-A1 | PLATINUM COMPLEX COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | L1CAM, LIG1, ZC3HAV1L | MAPT 1900/4885NPC1 3900/4885RAB9A 1622/4885 |
| US-20110234090-A1 | PLATINUM COMPLEX COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | L1CAM, LIG1, ZC3HAV1L | MAPT 1900/4885NPC1 3900/4885RAB9A 1622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.